Robison E, et al. – The impact of a postpartum risk–based low–molecular–weight heparin protocol for venous thromboembolism prevention is assessed in this study. Implementation of a low–molecular–weight heparin risk–based protocol for postpartum thromboembolism prevention resulted in high physician adherence and over 30% of postpartum women receiving enoxaparin. Before implementing such a protocol on a wider scale, a much larger study is needed to assess the impact on thromboembolic disease and wound problems.